Abstract
Stable Hb during 2 months, meaning that no value of
Hb, checked every second week, deviated from the last As a measurement of the amount of dialysis, Kt/V was Hb value by more than 5%. calculated using an equation based on an assumed urea 5. Serum concentration of ferritin exceeding 50 mg/l and distribution volume and the decrease in serum urea during a concentrations of vitamin B 12 and folic acid within dialysis session [14 ] . normal ranges. 6. Serum calcium and alkaline phosphatase within the Haemorheological variables normal ranges. 7. No blood transfusions received during the last 6 months.
Inverse viscosity is termed fluidity. Erythrocyte fluidity has Between a total of 77 haemodialysis patients, 25 subjects (17 been shown to reflect erythrocyte deformability [15] . In order men and 8 women) fulfilled the criteria. After explanation of to assess erythrocyte fluidity, the erythrocytes were separated the purpose of the study, all these patients gave their consent from plasma by centrifugation and re-suspended to a haemto participate in the study. Their mean age was 66 years atocrit of 55% in isotonic phosphate-buffered saline at (range 31-88 years). The primary renal diseases were pH 7.4. Erythrocyte fluidity was calculated as the inverse nephrosclerosis in nine patients, diabetic nephropathy in five, viscosity of the suspension, at a shear rate of 1 s−1 at 37°C chronic glomerulonephritis in three, congenital renal hypo-using a Low Shear 30 rotational viscometer (Contraves AG, plasia in two, renal artery stenosis in one, polycystic kidney Zü rich, Switzerland ). The plasma viscosity was determined disease in one, nephrectomia due to carcinoma in two, and at a shear rate of 38 s−1 at the same temperature using the unknown in two patients. The biochemical characteristics same instrument. The analyses were performed within 20 min are given in Table 1 . Nine of the patients were treated by after blood collection. In healthy subjects an erythrocyte haemodiafiltration and the remaining 16 by conventional fluidity of 101±6 Pa−1 s−1 and plasma viscosity of bicarbonate haemodialysis using modified cellulosic mem-1.24±0.04 mPa s have been found [16 ] . branes in 15 cases and a synthetic membrane in one case. Dialysis treatments were given twice weekly in nine patients
Statistical evaluation
and thrice weekly in 16 patients. No patients were on aluminium-containing phosphate binders. Iron supplementaValues are given as means ±SD. Unpaired two tailed t tests tion with iron sucrose was administered intravenously in and simple and multiple stepwise regression analyses were connection with dialysis to eight of the patients. rHuEpo used. The level of statistical significance was set at P<0.05. was administered subcutaneously at the end of the dialysis session by a member of the staff. Epoetin alpha was used in all cases. Blood samples were taken immediately before the start of a mid-week dialysis procedure.
Results
The normally distributed and consequently not suitable for regression analysis. Therefore the patients were divided into two groups with a CRP value lower or higher than 20 mg/l respectively. The Hb and serum albumin concentration were decreased and the reticulocyte fraction increased in the patients with a CRP concentration exceeding 20 mg/l ( Table 2) .
Discussion
The patients selected to participate in the present investigation had unaltered rHuEpo dose and stable Hb for at least 2 months prior to the investigation. They experienced no laboratory signs of known causes of rHuEpo hyporesponsiveness like iron deficiency, osteitis fibrosa, vitamin deficiency, or aluminium overload [17 ] . The weekly dose of rHuEpo needed to keep the Hb at a constant level did, however, vary greatly (56-370 U/kg/week). The doses were very closely related to the reticulocyte fraction. The reticulocyte fraction can be taken as an estimate of erythropoietic activity [18] . The finding of a close correlation between these two variables consequently indicates that the bone marrow response to rHuEpo did not vary much between different patients. Thus, the differences in required doses of rHuEpo cannot be explained by different degree of bone marrow inhibition in these patients.
Since our reticulocyte count findings indicate that the red blood cell formation rate was principally dependent on the doses of rHuEpo given, differences major factor explaining the differences in rHuEpo requirements. Blood loss, due to platelet dysfunction, haemodialysis, and periodic laboratory tests, is present used as dependent variable and Hb, serum (S ) albumin, S ferritin, S aluminium, S PTH, S urea, Kt/V/week, in haemodialysis patients and may be an important variable as regards the red blood cell disappearance erythrocyte deformability, and plasma viscosity were used as independent variables in a stepwise multiple rate [5 ] . Haemolysis may be another reason. In the present investigation erythrocyte deformability, measregression analysis, only erythrocyte fluidity remained significant. ured as erythrocyte fluidity, was the only variable significantly correlated with the required dose of In simple analysis of regression no correlation was found between erythrocyte fluidity and any of the rHuEpo in the stepwise multiple analysis of regression.
It is possible that impaired erythrocyte deformability variables listed in Table 1 .
Values of CRP concentration less than 10 mg/l were might give rise to haemolysis and thereby increased requirement of rHuEpo. not quantified. The majority of patients experienced a CRP value of 10 or less. Thus, these values were not However, the possibility of an opposite causative relationship between the required rHuEpo doses and inhibit erythropoiesis in vivo and in vitro. [29] . Our observation that the reticulocyte count was increased erythrocyte deformability must be borne in mind. Calcium ions are known to decrease membrane in the patients with a CRP exceeding 20 mg/l does, however, suggest an appropriate bone marrow deformability [19] and changes in red blood cell calcium homeostasis have been described during renal response to rHuEpo in these patients. Again, blood loss or shortened red blood cell life span seem to be anaemia treatment with rHuEpo [20] . In a previous study [21 ] we demonstrated a decreased erythrocyte important factors for the increased requirement of rHuEpo in these patients. However, the finding must deformability during the time period when the Hb value was increasing in rHuEpo-treated haemodialysis be interpreted with caution since the difference in reticulocyte count between the two groups was slight patients. When target Hb was reached, and the doses of rHuEpo were reduced, erythrocyte deformability, and a suboptimal method for the estimation of the variable was used. however, improved and reached values equal to those seen before treatment [21] . In the present investigation
In the present investigation, comprising selected haemodialysis patients without iron deficiency, alumithe patients had been treated with rHuEpo for at least 6 months and had had stable Hb during the last 2. nium intoxication, or any obvious signs suggestive for bone marrow fibrosis, the required doses of rHuEpo Thus, it seems unlikely that rHuEpo per se would cause decreased erythrocyte deformability in the pre-were closely related to the reticulocyte fraction. We therefore conclude that the interindividual differences sent investigation. Such a proposition is supported by findings from other studies where unchanged [4, 22] or in bone marrow response to rHuEpo were small in these patients. Our finding of a relationship between improved [23, 24] In a recent study increasing intensity of dialysis was mechanical properties of the red blood cells play a key role as regards the rHuEpo requirement. Based on the found to result in a significant increase in the haematocrit [25] . A high intensity of haemodialysis might result assumption that an increased CRP and plasma viscosity are indicative for inflammation, we also conclude in an improved erythrocyte deformability and thereby a low requirement of rHuEpo. Any significant correla-that inflammation may be an additional reason for increased rHuEpo requirement. tion between Kt/V and erythrocyte fluidity or required rHuEpo doses was, however, not found in the present Improvement in anaemia has also been reported after parathyroidectomy [26 ] . However, in the present References study no correlation was found between serum concen- inflammation is a factor associated with rHuEpo hypoDecreased deformability of erythrocytes and increased intracellular calcium in patients with chronic renal failure. Clin Hemorheol responsiveness [17 ] . In the present investigation the 
